about
Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia.Differentiation of autoimmune thrombocytopenia from thrombocytopenia associated with immune complex disease: systemic lupus erythematosus, hepatitis-cirrhosis, and HIV-1 infection by platelet and serum immunological measurements.Antiidiotype antibody against platelet anti-GPIIIa contributes to the regulation of thrombocytopenia in HIV-1-ITP patients.Prevalence of thrombocytopenia in HIV-infected and non-HIV infected drug users and homosexual men.Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway.Autoimmune thrombocytopenias.Immune-mediated thrombocytopenia in horses infected with equine infectious anemia virusAutoimmune anti-HIV-1gp120 antibody with antiidiotype-like activity in sera and immune complexes of HIV-1-related immunologic thrombocytopenia.Internal-image anti-idiotype HIV-1gp120 antibody in human immunodeficiency virus 1 (HIV-1)-seropositive individuals with thrombocytopeniaHematologic aspects of HIV disease: diagnostic and therapeutic considerations.Idiopathic thrombocytopenic purpura in HIV infection: therapeutic possibilities of intravenous immunoglobulins.The epidemiology of immune thrombocytopenia.Expression of CD4 by human megakaryocytes.Isolated thrombocytopenia in patients infected with HIV: treatment with intravenous gammaglobulin.Immunochemical analysis of platelet autoantibodies in HIV-related thrombocytopenic purpura: a study of 68 patients.Anti-F(ab')2 antibodies in thrombocytopenic patients at risk for acquired immunodeficiency syndrome.Platelet antibody: review of detection methods.Protein A immunoadsorption therapy in HIV-related immune thrombocytopenia: a preliminary report.Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addictsHigh-dose intravenous immunoglobulin and splenectomy for the treatment of HIV-related immune thrombocytopenia in patients with severe haemophilia.Haematologic manifestations of the human immune deficiency virus (HIV).Response to therapy in 37 patients with HIV-related thrombocytopenic purpura.Pathophysiology of HIV related thrombocytopenia: an analysis of 41 patients.Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patientsSplenectomy in human immunodeficiency virus-related thrombocytopenia.GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopeniaUsefulness of a low-dose intravenous immunoglobulin regimen for the treatment of thrombocytopenia associated with AIDS.Characterization of HIV-1-specific antibodies and HIV-1-crossreactive antibodies to platelets in HIV-1-infected haemophiliac patients.Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis.Markers predicting progression of human immunodeficiency virus-related disease.Epidemic human immunodeficiency virus (HIV) infection among intravenous drug users (IVDU)Medical complications of intravenous drug use.Recurrent and Massive Life Threatening Epistaxis due to Nasal Heroin Usage.DNA inoculation as a novel vaccination method against human retroviruses with rheumatic disease associations.Anticardiolipin antibodies associated with HTLV-III infection.Low incidence of bleeding from HIV-related thrombocytopenia in drug addicts and hemophiliacs: Implications for therapeutic strategies
P2860
Q31154319-D5D58DD2-AB22-41F2-945C-1EC3F7D9DE55Q33330532-22867E62-E0FE-4A08-8BEA-2F2A9759D30FQ33332866-40704C88-66B0-44D7-8E6B-35A56FD50E53Q33359182-BE4F4878-533C-41B0-AA28-C436E6C5DEF9Q33360225-7674ECE2-7852-4CB1-9721-A0951E459576Q33363539-D40ECFF4-A924-497C-A7AE-5691B45F6867Q33373647-B2625E79-F07C-4522-98EB-2B3EA2C981F5Q33374643-EF68386B-9899-487F-97C1-FB2692DFF35CQ33374816-16BEA6DE-AB6E-41C9-A867-08CB395F5CF1Q33384207-156AC4C4-0B63-44F6-BD18-08D8C5CEFDB1Q33392212-E4D9414E-05AD-475D-8670-4B5AE460B3F9Q33399809-CC1A223F-CC0B-4C15-9A31-4460D99180D3Q33399873-6514649D-B9F7-4EAA-83FB-291185ADD654Q33413463-CF97E7C1-A03D-452B-873B-536D41754988Q33429753-1CCE1FA8-D264-419C-BA14-43B8C74C2F86Q33445328-38F024A3-B64A-43BF-9BB1-10FA7AE728BFQ33445884-E9376B4D-A0FF-4113-B65E-592C1349F4B8Q33445982-D51DACD0-3836-4BD9-A204-91082A2874DAQ33448415-0B17C686-7726-4F95-A639-56F072CABD85Q33449059-061BE522-B190-4389-9D10-9E8FE4FC082AQ33454451-48172116-5808-42EE-9CD4-CF14CDE4899EQ33455086-9C23C651-B4D6-4D91-9780-B381B65A06A4Q33490242-3A93EA17-1224-42A7-9225-94F755A66D93Q33490716-4DA3A35A-8CAA-4267-9251-616FE0E9BAC8Q33494646-7BE97FC6-79FE-413D-8C91-DFF19D82398EQ33499685-D25DD2B1-D8E4-4A15-9177-ADFDBBFE4CE9Q33503865-8B639F42-1497-4D7F-B191-AC63B6FAA6B4Q33504907-0A65CBE9-E3F4-422B-8CB8-8E97B99F7EEFQ33835844-85CE99E4-EC3F-4251-9814-8E344E325052Q36640801-ACD0E9ED-F8B1-4B02-A3EC-9843259342E1Q36989554-97341201-DAE7-4C08-A1E3-0832B302F019Q37924215-90A11D0F-7CF2-4E3B-AF1D-6431050DA8F2Q38438974-B5C179A6-B0D0-4055-9CFB-AF0D3281DB76Q40541784-750F7246-AFC4-4E3A-9579-CB5C5AEC0F55Q55243046-20229C88-4A1E-4ECC-82C7-C4AAF6DA8BF8Q58292848-E3D90400-F3E6-4380-B7FA-3861BDDF300F
P2860
description
1985 nî lūn-bûn
@nan
1985 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Thrombocytopenic purpura in narcotics addicts.
@ast
Thrombocytopenic purpura in narcotics addicts.
@en
type
label
Thrombocytopenic purpura in narcotics addicts.
@ast
Thrombocytopenic purpura in narcotics addicts.
@en
prefLabel
Thrombocytopenic purpura in narcotics addicts.
@ast
Thrombocytopenic purpura in narcotics addicts.
@en
P2093
P1476
Thrombocytopenic purpura in narcotics addicts
@en
P2093
E T Lennette
S Karpatkin
P304
P356
10.7326/0003-4819-102-6-737
P407
P577
1985-06-01T00:00:00Z